When examining MAZ levels in liver cancer, we observed increased MAZ expression in various HCC cell lines and 8 liver cancer samples, compared to nontumorigenic hepatic HL-7702 cells and matched normal liver tissues, respectively (Supplementary Fig. 8a–c). This evidence concerns the gene MAZ and hepatocellular carcinoma.